Page 5 - Patrickj Haley News Today

A number of research firms have changed their ratings and price targets for Exelixis (NASDAQ: EXEL): 4/14/2023 – Exelixis was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 4/12/2023 – Exelixis had its price target lowered by analysts at Morgan Stanley from $22.00 to $21.00. They now have an “equal […]

Exelixis (NASDAQ:EXEL – Get Rating) had its target price trimmed by Morgan Stanley from $22.00 to $21.00 in a research report released on Wednesday morning, The Fly reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. EXEL has been the topic of a number of other reports. Wells Fargo & […]

StockNews.com downgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a buy rating to a hold rating in a research report report published on Thursday morning. Other equities analysts have also recently issued reports about the company. Truist Financial reduced their target price on Exelixis from $35.00 to $32.00 in a research note on Friday, […]

Stephens Investment Management Group LLC trimmed its stake in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,047,250 shares of the biotechnology company’s stock after selling 25,961 shares during the quarter. Exelixis accounts for 1.1% […]

StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday. EXEL has been the subject of several other reports. EF Hutton Acquisition Co. I reiterated a buy rating and set a $24.00 target price on shares of Exelixis in a […]

StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a hold rating to a buy rating in a research note released on Wednesday. Several other analysts also recently issued reports on the stock. Piper Sandler reissued an overweight rating and set a $32.00 target price on shares of Exelixis in a research note on […]

Should You Buy or Sell Exelixis Stock? Get The Latest EXEL Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Northern Trust Corp trimmed its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 2,443,152 shares of the biotechnology company’s stock after selling 29,166 shares during the quarter. Northern Trust Corp’s holdings in Exelixis were worth $50,867,000 as of its most […]

Treasurer of the State of North Carolina increased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.6% during the 1st quarter, HoldingsChannel reports. The firm owned 114,029 shares of the biotechnology company’s stock after purchasing an additional 1,805 shares during the period. Treasurer of the State of North Carolina’s holdings in […]

M&T Bank Corp bought a new stake in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 9,992 shares of the biotechnology company’s stock, valued at approximately $228,000. Other hedge funds and other institutional investors […]